InsidersTradesSigma
Alaunos Therapeutics, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)
Track the Alaunos Therapeutics, Inc. share price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Health Care sector, Alaunos Therapeutics, Inc. has recorded 19 insider filings. Market capitalisation: €5.1m. The latest transaction was reported on 2 July 2026 (Attribution). Among the most active insiders: Weis Holger. All data is accessible without an account.
19
Insider Decl.
0
Thresholds
€1m
2 ops.
Buy Volume
€13,014
2 ops.
Sell Volume
49Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 July 2026
Declarations19 total
3,880 sharesCommon StockSEC:0001193125-26-295004:0
7,761 sharesCommon StockSEC:0001193125-26-274305:0
3,700 shares@ US$2.370.12% mcap100.0% of flowCommon StockSEC:0001193125-26-241999:0
20,804 shares@ US$2.9210.2% of flowCommon StockSEC:0000950170-25-054436:0
17,465 shares0Common StockSEC:0000950170-25-054429:0
2,182 shares@ US$2.010.5% of flowCommon StockSEC:0000950170-25-001257:0
68,014 shares@ US$0.140316.3% of flowCommon StockSEC:0000950170-23-046504:0
750,000 shares@ US$0.6589.8% of flowCommon StockSEC:0000899243-22-037275:0
Ideal exit: 26 Aug 2023 (T+270)
1,250,000 shares@ US$0.6599.5% of flowCommon StockSEC:0000899243-22-037274:0
Ideal exit: 26 Aug 2023 (T+270)
18,750 shares@ US$2.4183.7% of flowCommon StockSEC:0000899243-22-030186:0
40,000 shares0Common StockSEC:0000899243-22-023978:0
40,000 shares0Common StockSEC:0000899243-22-024005:0
80,000 shares0Common StockSEC:0000899243-22-024006:0
80,000 shares0Common StockSEC:0000899243-22-023988:0
40,000 shares0Common StockSEC:0000899243-22-024011:0
40,000 shares0Common StockSEC:0000899243-22-023985:0
40,000 shares0Common StockSEC:0000899243-22-023977:0
40,000 shares0Common StockSEC:0000899243-22-023997:0
40,000 shares0Common StockSEC:0000899243-22-023987:0
19 of 19 declarations
About Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. is a biopharmaceutical company focused on developing cell therapies for cancer treatment. It utilizes innovative technology to create personalized treatments for patients.